Consistent with this, the proportion of HCC cells entering the S phase increased with ZYX overexpression, whereas silencing ZYX significantly decreased the proportion of proliferative cells in the S phase (Fig. 4A). The gene discussed is ZYX; the disease is hepatocellular carcinoma.